226 related articles for article (PubMed ID: 32017221)
21. Subcutaneous administration of human C1 inhibitor with recombinant human hyaluronidase in patients with hereditary angioedema.
Riedl MA; Lumry WR; Li HH; Banerji A; Bernstein JA; Ba M; Bjrkander J; Magerl M; Maurer M; Rockich K; Chen H; Schranz J
Allergy Asthma Proc; 2016 Nov; 37(6):489-500. PubMed ID: 27931305
[TBL] [Abstract][Full Text] [Related]
22. Hereditary angioedema: Historical aspects, classification, pathophysiology, clinical presentation, and laboratory diagnosis.
Khan DA
Allergy Asthma Proc; 2011; 32(1):1-10. PubMed ID: 21262092
[TBL] [Abstract][Full Text] [Related]
23. Short-term prophylaxis in patients with angioedema due to C1-inhibitor deficiency undergoing dental procedures: An observational study.
Zanichelli A; Ghezzi M; Santicchia I; Vacchini R; Cicardi M; Sparaco A; Donati G; Ranìa V; Busa A
PLoS One; 2020; 15(3):e0230128. PubMed ID: 32163480
[TBL] [Abstract][Full Text] [Related]
24. The safety of treatments for angioedema with hereditary C1 inhibitor deficiency.
Zanichelli A; Wu MA; Andreoli A; Mansi M; Cicardi M
Expert Opin Drug Saf; 2015; 14(11):1725-36. PubMed ID: 26429506
[TBL] [Abstract][Full Text] [Related]
25. Recognition, Evaluation, and Management of Pediatric Hereditary Angioedema.
Krack AT; Bernstein JA; Ruddy RM
Pediatr Emerg Care; 2021 Apr; 37(4):218-223. PubMed ID: 33780405
[TBL] [Abstract][Full Text] [Related]
26. Hereditary angioedema in Greece: the first results of the greek hereditary angioedema registry.
Psarros F; Koutsostathis N; Farmaki E; Speletas MG; Germenis AE
Int Arch Allergy Immunol; 2014; 164(4):326-32. PubMed ID: 25277223
[TBL] [Abstract][Full Text] [Related]
27. Hereditary angioedema with normal C1 inhibitor: clinical characteristics and treatment response with plasma-derived human C1 inhibitor concentrate (Berinert
Bouillet L; Boccon-Gibod I; Gompel A; Floccard B; Martin L; Blanchard-Delaunay C; Launay D; Fain O
Eur J Dermatol; 2017 Apr; 27(2):155-159. PubMed ID: 28251901
[TBL] [Abstract][Full Text] [Related]
28. [Hereditary angioedema--pathophysiology, genetics, symptoms].
Muszyńska A; Janocha E; Fal AM
Pol Merkur Lekarski; 2008 Jul; 25(145):90-3. PubMed ID: 18839624
[TBL] [Abstract][Full Text] [Related]
29. Clinical and genetic features of hereditary angioedema with and without C1-inhibitor (C1-INH) deficiency in Japan.
Hashimura C; Kiyohara C; Fukushi JI; Hirose T; Ohsawa I; Tahira T; Horiuchi T
Allergy; 2021 Nov; 76(11):3529-3534. PubMed ID: 34343365
[No Abstract] [Full Text] [Related]
30. Hereditary Angioedema with Normal C1 Inhibitor and F12 Mutations in 42 Brazilian Families.
Veronez CL; Moreno AS; Constantino-Silva RN; Maia LSM; Ferriani MPL; Castro FFM; Valle SR; Nakamura VK; Cagini N; Gonçalves RF; Mansour E; Serpa FS; Coelho Dias GA; Piccirillo MA; Toledo E; de Souza Bernardes M; Cichon S; Stieber C; Arruda LK; Pesquero JB; Grumach AS
J Allergy Clin Immunol Pract; 2018; 6(4):1209-1216.e8. PubMed ID: 29128335
[TBL] [Abstract][Full Text] [Related]
31. Misdiagnosis trends in patients with hereditary angioedema from the real-world clinical setting.
Zanichelli A; Longhurst HJ; Maurer M; Bouillet L; Aberer W; Fabien V; Andresen I; Caballero T;
Ann Allergy Asthma Immunol; 2016 Oct; 117(4):394-398. PubMed ID: 27742086
[TBL] [Abstract][Full Text] [Related]
32. Genetics of Hereditary Angioedema Revisited.
Germenis AE; Speletas M
Clin Rev Allergy Immunol; 2016 Oct; 51(2):170-82. PubMed ID: 27116602
[TBL] [Abstract][Full Text] [Related]
33. Costs and effects of on-demand treatment of hereditary angioedema in Italy: a prospective cohort study of 167 patients.
Federici C; Perego F; Borsoi L; Crosta V; Zanichelli A; Gidaro A; Tarricone R; Cicardi M
BMJ Open; 2018 Jul; 8(7):e022291. PubMed ID: 30061443
[TBL] [Abstract][Full Text] [Related]
34. Hereditary angioedema: a brief review of new developments.
Altman KA; Naimi DR
Curr Med Res Opin; 2014 May; 30(5):923-30. PubMed ID: 24432781
[TBL] [Abstract][Full Text] [Related]
35. Delayed diagnosis of hereditary angioedema with C1-inhibitor deficiency in iranian children and adolescents.
Ayazi M; Fazlollahi MR; Mohammadzadeh I; Fayezi A; Nabavi M; Mahdaviani SA; Movahedi M; Heidarzadeh M; Saghafi S; Shokouhi Shoormasti R; Mohammadian S; Farkas H; Pourpak Z
Pediatr Allergy Immunol; 2019 May; 30(3):395-398. PubMed ID: 30690789
[No Abstract] [Full Text] [Related]
36. Current treatment options for hereditary angioedema due to C1 inhibitor deficiency.
Wu MA; Zanichelli A; Mansi M; Cicardi M
Expert Opin Pharmacother; 2016; 17(1):27-40. PubMed ID: 26512744
[TBL] [Abstract][Full Text] [Related]
37. Treatment of Hereditary Angioedema Attacks with Icatibant and Recombinant C1 Inhibitor During Pregnancy.
Hakl R; Kuklínek P; Krčmová I; Králíčková P; Freiberger T; Janků P; Vlková M; Litzman J
J Clin Immunol; 2018 Oct; 38(7):810-815. PubMed ID: 30280305
[TBL] [Abstract][Full Text] [Related]
38. The role of the complement system in hereditary angioedema.
Csuka D; Veszeli N; Varga L; Prohászka Z; Farkas H
Mol Immunol; 2017 Sep; 89():59-68. PubMed ID: 28595743
[TBL] [Abstract][Full Text] [Related]
39. Clinical manifestations, diagnosis, and treatment of hereditary angioedema: survey data from 94 physicians in Japan.
Ohsawa I; Honda D; Nagamachi S; Hisada A; Shimamoto M; Inoshita H; Mano S; Tomino Y
Ann Allergy Asthma Immunol; 2015 Jun; 114(6):492-8. PubMed ID: 25872948
[TBL] [Abstract][Full Text] [Related]
40. Health-Related Quality of Life with Subcutaneous C1-Inhibitor for Prevention of Attacks of Hereditary Angioedema.
Lumry WR; Craig T; Zuraw B; Longhurst H; Baker J; Li HH; Bernstein JA; Anderson J; Riedl MA; Manning ME; Keith PK; Levy DS; Caballero T; Banerji A; Gower RG; Farkas H; Lawo JP; Pragst I; Machnig T; Watson DJ
J Allergy Clin Immunol Pract; 2018; 6(5):1733-1741.e3. PubMed ID: 29391286
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
